Predictions
Inventiva SA
Start price
Target price
Perf. (%)
€3.31
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€3.31
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€20.18
03.09.21
03.09.21
€30.00
03.09.22
03.09.22
-59.38%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business
Valneva SE
Start price
Target price
Perf. (%)
€13.84
25.08.21
25.08.21
-
25.08.22
25.08.22
-32.23%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€5.10
30.07.21
30.07.21
-
30.07.22
30.07.22
2.55%
08.08.21
08.08.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Sanofi S.A.
Start price
Target price
Perf. (%)
€86.85
08.07.21
08.07.21
€115.00
08.07.22
08.07.22
13.32%
08.07.22
08.07.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Sanofi S.A.
Start price
Target price
Perf. (%)
€86.85
08.07.21
08.07.21
€115.00
08.07.22
08.07.22
13.32%
08.07.22
08.07.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Sanofi S.A.
Start price
Target price
Perf. (%)
€86.85
08.07.21
08.07.21
€115.00
08.07.22
08.07.22
13.32%
08.07.22
08.07.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Abivax S.A.
Start price
Target price
Perf. (%)
€30.50
28.06.21
28.06.21
€25.00
28.06.22
28.06.22
-16.39%
01.12.21
01.12.21
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE
Start price
Target price
Perf. (%)
€10.89
17.06.21
17.06.21
€8.00
17.06.22
17.06.22
3.21%
20.07.21
20.07.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Virbac S.A.
Start price
Target price
Perf. (%)
€275.00
28.04.21
28.04.21
€270.00
28.04.22
28.04.22
43.82%
25.10.21
25.10.21
Could be worthwhile Investment >10% per year
Boiron S.A.
Start price
Target price
Perf. (%)
€38.55
13.04.21
13.04.21
€36.00
13.04.22
13.04.22
-1.30%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€8.16
15.01.21
15.01.21
-
15.01.22
15.01.22
-63.58%
16.01.22
16.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Innate Pharma
Start price
Target price
Perf. (%)
€4.10
15.11.20
15.11.20
€5.50
15.11.21
15.11.21
7.86%
16.11.21
16.11.21
Could be worthwhile Investment >10% per year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.45
03.11.20
03.11.20
-
04.11.21
04.11.21
136.51%
15.01.21
15.01.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group